NCT03490942 - Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 15, 2018

Primary Completion Date

November 4, 2019

Study Completion Date

February 10, 2020

Conditions

Hypoglycemia UnawarenessDiabetes Mellitus, Type 1

Interventions

DRUG

Glucagon

CSI-Glucagon is a room temperature stable, non-aqueous, liquid formulation of glucagon.

DRUG

Placebo

The placebo solution is a non-active formulation containing excipients only.

Trial Locations (5)

University of Pennsylvania, Philadelphia

Emory University - Grady Memorial Hospital, Atlanta

Atlanta Diabetes Associates, Atlanta

University of Alabama, Birmingham, Birmingham

University of California, San Diego, San Diego